Related Experiment Video
Updated: Jun 25, 2026
08:22
Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference
Published on: July 30, 2013
Vaccines for cocaine abuse.
Frank M Orson1, Berma M Kinsey, Rana A K Singh
1Veterans Affairs Medical Center, Houston, TX 77030, USA. forson@bcm.tmc.edu
Human Vaccines
|March 12, 2009
Summary
New cocaine vaccines show promise by using antibodies to block the drug from reaching the brain. This innovative approach may help individuals overcome cocaine abuse by reducing its effects.
Area of Science:
- Pharmacology
- Immunology
- Addiction Medicine
Background:
- Current cocaine abuse treatments are largely ineffective.
- Vaccination strategies offer a novel therapeutic avenue.
- Antibodies can potentially mitigate cocaine's central nervous system effects.
Purpose of the Study:
- To review the development and potential of anti-cocaine vaccines.
- To discuss the mechanism of action for antibody-based cocaine blockade.
- To present the current status of cocaine conjugate vaccine development.
Main Methods:
- Review of preclinical animal models and human trials.
- Analysis of antibody-drug binding in circulation.
- Evaluation of antibody properties (quantitative and qualitative).
Main Results:
- Anti-cocaine antibodies show promise in blocking cocaine's access to the brain.
- Antibody binding in circulation reduces central nervous system entry and effects.
- Vaccine effectiveness depends on antibody characteristics.
Conclusions:
- Cocaine conjugate vaccines represent a promising strategy for addiction treatment.
- Further development is needed to optimize vaccine efficacy.
- Successful clinical application hinges on tailored antibody responses.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...